Related Experiment Video
Updated: Mar 12, 2026
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
At the crossroads of cancer stem cells and targeted therapy resistance
Anbang Wang1, Le Qu2, Linhui Wang1
1Department of Urology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China.
Abstract:
Small-molecule targeted therapy (TT) has brought great hopes to patients with advanced malignancies. However, most patients suffer from tumor progression and relapse due to drug resistance. Recently, considerable efforts trying to elucidate the underlying mechanisms have focused on the contribution of cancer stem cells (CSCs) to the targeted therapy resistance (TTR). In this article, we provide an overview of the currently available literature on the rising roles of CSCs in TTR, as well as therapeutic opportunities of combining TT and anti-CSC therapy in the treatment of advanced malignancies.
Insights
Small-molecule targeted therapy (TT) shows promise for advanced cancers, but drug resistance, often linked to cancer stem cells (CSCs), leads to relapse. Combining TT with anti-CSC strategies may overcome this resistance.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Background:
- Small-molecule targeted therapy (TT) offers hope for advanced malignancies.
- Tumor progression and relapse due to drug resistance remain significant challenges.
- Cancer stem cells (CSCs) are increasingly implicated in targeted therapy resistance (TTR).
Purpose of the Study:
- To review the literature on the role of CSCs in TTR.
- To explore therapeutic strategies combining TT and anti-CSC treatments for advanced cancers.
Main Methods:
- Literature review of studies investigating CSCs and TTR.
- Analysis of current therapeutic approaches and their combination potential.
Main Results:
- CSCs play a crucial role in the development of TTR.
- Combining TT with anti-CSC therapies presents a promising strategy.
Conclusions:
- Targeted therapy resistance in advanced malignancies is significantly influenced by CSCs.
- Combined therapeutic approaches targeting both cancer cells and CSCs are essential for improving treatment outcomes.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
02:56Treatment Resistant Cancers
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:56Treatment Resistent Cancers